🇺🇸 SRPT — Sarepta Therapeutics, Inc.

Salud Mantener
← Volver

Precio actual

17,57 USD

Máx. histórico

178,74

2144 días

Split 1:6 del 12/07/2012

Caída desde máximo

-90,17%

Rango 52 semanas

14,68 – 24,68

Variación hoy

-7,48%

Cierre anterior

18,99

Rango de hoy

17,44 – 18,92

Volumen hoy

1.859.162

Peor caída histórica

-98,17%

09/02/2000 → 18/12/2008

Recuperado en 3568 días

Volatilidad anualizada ⓘ

95,43%

Información
Nombre completo
Sarepta Therapeutics, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
835
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
21,64 USD (puede no estar actualizado)
Primera cotización
04/06/1997
Precio actualizado
hace 9 horas
Sobre la empresa

Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, siRNA platform, gene therapy, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; VYONDYS 53 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 53 skipping; AMONDYS 45 for the treatment of Duchenne in patients who have a confirmed mutation of the dystrophin gene that is amenable to exon 45 skipping; and ELEVIDYS, an AAV-based gene therapy, which is contraindicated in patients with any deletion in exon 8 and/or exon 9 in the Duchenne gene. The company also develops SRP-9003, a gene therapy program for the treatment of LGMD2E; SRP-1001 to selectively target and knockdown DUX4 using RNAi in Phase 1/2a clinical trials; and SRP-1003 for reduction of expression of the DMPK gene in Phase 1/2a clinical trials. It has collaboration and license agreements with F. Hoffman-La Roche Ltd; Arrowhead Pharmaceuticals, Inc.; University of Western Australia; Nationwide Children's Hospital; Hansa Biopharma; and Duke University. The company was incorporated in 1980 and is headquartered in Cambridge, Massachusetts.

Splits Registrados en el histórico de precios
Fecha Ratio
12/07/2012 1:6
Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
26/03/2021 75,06 75,58 73,73 74,78 +0,12% 2,46% 952.200
25/03/2021 73,88 75,48 72,14 74,69 -0,39% 4,52% 1.035.800
24/03/2021 79,28 79,28 74,90 74,98 -4,58% 5,52% 1.357.300
23/03/2021 83,00 83,47 78,48 78,58 -5,93% 6,01% 1.431.400
22/03/2021 83,18 84,31 82,39 83,53 +1,08% 2,31% 1.130.300
19/03/2021 85,91 85,95 81,99 82,64 -0,43% 4,61% 2.152.900
18/03/2021 84,12 86,19 82,40 83,00 -2,17% 4,51% 847.200
17/03/2021 84,20 85,66 83,00 84,84 +0,47% 3,16% 522.600
16/03/2021 86,45 88,39 83,54 84,44 -1,75% 5,61% 964.700
15/03/2021 86,52 87,00 85,02 85,94 -0,61% 2,29% 829.700
12/03/2021 87,16 87,16 84,78 86,47 -0,80% 2,73% 482.100
11/03/2021 84,69 87,60 84,46 87,17 +3,15% 3,71% 670.300
10/03/2021 87,64 87,64 84,41 84,51 -1,45% 3,69% 824.600
09/03/2021 84,17 87,59 84,00 85,75 +3,05% 4,27% 836.700
08/03/2021 84,23 86,05 82,62 83,21 -1,86% 4,07% 1.016.000
05/03/2021 83,00 85,49 78,31 84,79 +3,20% 8,65% 1.777.300
04/03/2021 86,41 89,49 81,97 82,16 -5,68% 8,70% 1.520.500
03/03/2021 88,36 91,62 86,86 87,11 -2,05% 5,39% 1.257.500
02/03/2021 85,34 90,00 85,10 88,93 +2,18% 5,74% 1.820.600
01/03/2021 87,59 88,73 86,15 87,03 -0,03% 2,95% 1.354.300
26/02/2021 85,87 87,68 82,27 87,06 +2,12% 6,30% 1.567.300
25/02/2021 83,65 89,49 81,58 85,25 +1,14% 9,46% 3.120.800
24/02/2021 84,23 85,42 82,80 84,29 +0,56% 3,11% 983.200
23/02/2021 81,20 84,78 77,01 83,82 +0,85% 9,57% 1.551.000
22/02/2021 86,10 86,11 82,76 83,11 -2,66% 3,89% 1.314.700
19/02/2021 89,00 90,80 84,95 85,38 -3,36% 6,57% 1.962.100
18/02/2021 88,14 89,25 85,80 88,35 -1,40% 3,91% 989.900
17/02/2021 90,29 90,55 87,31 89,60 -1,41% 3,59% 1.196.700
16/02/2021 91,73 92,50 90,00 90,88 -0,21% 2,73% 838.800
12/02/2021 90,83 92,40 89,39 91,07 +0,33% 3,31% 795.300